{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:48Z","timestamp":1791828588842,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021729","name":"University of Freiburg Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002714","name":"Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ymgme.2025.109054","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T19:06:27Z","timestamp":1739300787000},"page":"109054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Kidney involvement in glycogen storage disease type I: Current knowledge and key challenges"],"prefix":"10.1016","volume":"144","author":[{"given":"Anke","family":"Schumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven F.","family":"Garbade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skadi","family":"Beblo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Gautschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Hochuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Scholl-B\u00fcrgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Thimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Weinhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Wortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Gr\u00fcnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109054_bb0005","series-title":"GeneReviews\u00ae","article-title":"Glycogen storage disease type I","author":"Bali","year":"1993"},{"key":"10.1016\/j.ymgme.2025.109054_bb0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/TRD-160006","article-title":"Glyogen storage diseases: diagnosis, treatment and outcome","volume":"1","author":"Chen","year":"2016","journal-title":"Transl. Sci. Rare Diseas."},{"key":"10.1016\/j.ymgme.2025.109054_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2014.128","article-title":"American College of Medical Genetics and Genomics, diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2025.109054_bb0020","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1067\/mpd.2001.111322","article-title":"Decreased urinary citrate excretion in type 1a glycogen storage disease","volume":"138","author":"Weinstein","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109054_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1442-2042.2003.00569.x","article-title":"Calcium nephrolithiasis and distal tubular acidosis in type 1 glycogen storage disease","volume":"10","author":"Iida","year":"2003","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ymgme.2025.109054_bb0030","first-page":"645","article-title":"Multiple calcium oxalate stone formation in a patient with glycogen storage disease type I (von Gierke\u2019s disease) and renal tubular acidosis type I: a case report","volume":"39","author":"Kanematsu","year":"1993","journal-title":"Hinyokika Kiyo"},{"key":"10.1016\/j.ymgme.2025.109054_bb0035","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2215\/CJN.00050109","article-title":"Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition","volume":"4","author":"Martens","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2025.109054_bb0040","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.1989.133","article-title":"Hyperfiltration and renal disease in glycogen storage disease, type I","volume":"35","author":"Baker","year":"1989","journal-title":"Kidney Int."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2025.109054_bb0045","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1007\/BF02072091","article-title":"Renal complications in glycogen storage disease type I","volume":"152","author":"Reitsma-Bierens","year":"1993","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109054_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM198801073180102","article-title":"Renal disease in type I glycogen storage disease","volume":"318","author":"Chen","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2025.109054_bb0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/pedi.12540","article-title":"Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control","volume":"18","author":"Dambska","year":"2017","journal-title":"Pediatr. Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2025.109054_bb0060","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1007\/BF02679990","article-title":"Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I)","volume":"161","author":"Rake","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109054_bb0065","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ymgme.2019.02.008","article-title":"Glycemic control and complications in glycogen storage disease type I: results from the Swiss registry","volume":"126","author":"Kaiser","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2025.109054_bb0070","first-page":"S120","article-title":"European study on glycogen storage disease type I, consensus guidelines for management of glycogen storage disease type 1b - European study on glycogen storage disease type 1","volume":"161","author":"Visser","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109054_bb0075","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10545-017-0054-2","article-title":"Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy","volume":"40","author":"Okechuku","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109054_bb0080","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/sj.ki.5002718","article-title":"Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia","volume":"73","author":"Yiu","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2025.109054_bb0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1023\/A:1005346824368","article-title":"Metabolic control and renal dysfunction in type I glycogen storage disease","volume":"20","author":"Wolfsdorf","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109054_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2265.2005.02292.x","article-title":"Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study","volume":"63","author":"Melis","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ymgme.2025.109054_bb0095","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jpeds.2014.12.015","article-title":"Progression of renal damage in glycogen storage disease type I is associated to hyperlipidemia: a multicenter prospective Italian study","volume":"166","author":"Melis","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109054_bb0100","first-page":"52","article-title":"The natural history of glycogen storage disease type Ib in England: a multisite survey","volume":"59","author":"Halligan","year":"2021","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2025.109054_bb0105","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3390\/biom13071075","article-title":"Should cystatin C eGFR become routine clinical practice?","volume":"13","author":"Spencer","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymgme.2025.109054_bb0110","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"CKD prognosis consortium, cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2025.109054_bb0115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2215\/CJN.11480821","article-title":"SGLT2 inhibition and uric acid excretion in patients with type 2 diabetes and Normal kidney function","volume":"17","author":"Suijk","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2025.109054_bb0120","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.kint.2020.04.051","article-title":"Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes","volume":"98","author":"Li","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2025.109054_bb0125","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3389\/fped.2020.00591","article-title":"Kidney and metabolic phenotypes in glycogen storage disease type-I patients","volume":"8","author":"Aoun","year":"2020","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109054_bb0130","first-page":"23","article-title":"Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I","volume":"18","author":"Beegle","year":"2015","journal-title":"JIMD Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2025.109054_bb0135","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1007\/BF02679991","article-title":"Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease","volume":"161","author":"Weinstein","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109054_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.ajkd.2006.04.077","article-title":"Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data","volume":"48","author":"MacKinnon","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ymgme.2025.109054_bb0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.diabet.2013.03.002","article-title":"Glycogen storage disease type 1 and diabetes: learning by comparing and contrasting the two disorders","volume":"39","author":"Rajas","year":"2013","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ymgme.2025.109054_bb0150","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/labinvest.2010.38","article-title":"Oxidative stress mediates nephropathy in type Ia glycogen storage disease","volume":"90","author":"Yiu","year":"2010","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ymgme.2025.109054_bb0155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0306-9877(02)00199-8","article-title":"Glycogenosis type I and diabetes mellitus: a common mechanism for renal dysfunction?","volume":"59","author":"Mundy","year":"2002","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ymgme.2025.109054_bb0160","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1681\/ASN.2021070935","article-title":"Dapagliflozin prevents kidney glycogen accumulation and improves renal proximal tubule cell functions in a mouse model of glycogen storage disease type 1b","volume":"33","author":"D\u2019Acierno","year":"2022","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225000459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225000459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:45:41Z","timestamp":1762364741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225000459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1096719225000459"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109054","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney involvement in glycogen storage disease type I: Current knowledge and key challenges","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109054"}}